4DMedical Ltd (AU:4DX) has released an update.
4DMedical Limited invites shareholders and interested parties to an investor webinar on October 1, 2024, to be briefed by CEO Dr. Andreas Fouras on the company’s latest developments. The Australian-based global medical technology firm, known for its advanced respiratory imaging technology, recently acquired Imbio, a company specializing in AI medical imaging solutions. The webinar will provide insight into 4DMedical’s innovative XV Technology® and its impact on the diagnosis and treatment of respiratory diseases.
For further insights into AU:4DX stock, check out TipRanks’ Stock Analysis page.